Cart
sales@molnova.com
Growth hormone releasing peptide
CAS No. 87616-84-0
Growth hormone releasing peptide( —— )
Catalog No. M20497 CAS No. 87616-84-0
Growth hormone releasing peptide ia a natual product and has anti-inflammatory effects due to its inhibitory effect on PKC-induced activation of p38 JNK and NF-κB possibly by targeting to MKP-1 and PP2A.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 49 | In Stock |
|
| 10MG | 60 | In Stock |
|
| 25MG | 115 | In Stock |
|
| 50MG | 177 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGrowth hormone releasing peptide
-
NoteResearch use only, not for human use.
-
Brief DescriptionGrowth hormone releasing peptide ia a natual product and has anti-inflammatory effects due to its inhibitory effect on PKC-induced activation of p38 JNK and NF-κB possibly by targeting to MKP-1 and PP2A.
-
DescriptionGrowth hormone releasing peptide ia a natual product and has anti-inflammatory effects due to its inhibitory effect on PKC-induced activation of p38 JNK and NF-κB possibly by targeting to MKP-1 and PP2A.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetPPAR
-
RecptorPP2A
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number87616-84-0
-
Formula Weight873
-
Molecular FormulaC46H56N12O6?
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(N)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Yi-Ning C David S Yen-Chun P et al. Growth Hormone Releasing Peptide-2 Attenuation of Protein Kinase C-Induced Inflammation in Human Ovarian Granulosa Cells[J]. International Journal of Molecular Sciences 2016 17(8):1359-.
molnova catalog
related products
-
CGS 15435
CGS 15435 is a potent thromboxen (TxA2) synthetase inhibitor (IC50: 1 nM). CGS 15435 acts on PGI2 synthase, cyclooxygenase and liposynthase with much less selectivity than on thromboxin synthase.
-
Furegrelate sodium
Furegelate sodium is a selective thromboxane synthase inhibitor with oral activity.
-
K-111
K-111 (BM-170744) is an orally available peroxisome proliferator-activated receptor (PPAR)-alpha agonist and insulin enhancer for the study of obesity-type diabetes mellitus and the metabolic syndrome.
